protoberberine has been researched along with stepholidine in 2 studies
Studies (protoberberine) | Trials (protoberberine) | Recent Studies (post-2010) (protoberberine) | Studies (stepholidine) | Trials (stepholidine) | Recent Studies (post-2010) (stepholidine) |
---|---|---|---|---|---|
148 | 0 | 72 | 115 | 2 | 22 |
Protein | Taxonomy | protoberberine (IC50) | stepholidine (IC50) |
---|---|---|---|
Tissue factor | Homo sapiens (human) | 0.1046 | |
D(2) dopamine receptor | Homo sapiens (human) | 2.2427 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.0123 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lei, S; Mulvany, MJ; Orensanz, LM; Simonsen, U | 1 |
Chen, K; Gao, B; Guo, L; Jiang, H; Li, Z; Liu, H; Qian, W; Sun, H; Yang, H; Zhen, X; Zhou, S; Zhou, Y; Zhu, L | 1 |
2 other study(ies) available for protoberberine and stepholidine
Article | Year |
---|---|
Mechanisms involved in the vasorelaxant effect of (-)-stepholidine in rat mesenteric small arteries.
Topics: Animals; Berberine; Berberine Alkaloids; Calcium Channels; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Potassium Channels; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Muscarinic; Serotonin | 1999 |
Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
Topics: Animals; Antipsychotic Agents; Berberine; Berberine Alkaloids; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Microwaves; Motor Activity; Protein Binding; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |